12236-82-7 Purity
96%
If you have any other questions or need other size, please get a quote.
Specification
The preparation of electrospun nanofiber membranes for the ultra-fast delivery of Domperidone (10 mg) involves a precise formulation process to ensure uniform drug dispersion and optimal release characteristics. Polyvinyl alcohol (PVA) is dissolved in a water-DMSO (4:1) mixture and stirred for 2 hours. The Domperidone is then incorporated into the PVA solution, followed by another hour of stirring to form a homogeneous mixture. A blank solution, prepared without the drug, serves as a control.
The electrospinning process is carried out using laboratory-scale equipment, with a grounded metal electrode and polyethylene target sheet to collect the nanofibers. The solution is fed into a 100 µL syringe attached to a 0.52 mm metal needle, with the feed rate varying between 0.125-0.375 mL/min, and voltage settings ranging from 11-15 kV. The distance from the syringe tip to the collector is maintained at 10 cm. Nanofibers are collected on a polyethylene mesh-covered collector connected to the grounded electrode.
The resulting electrospun membranes are stored in a desiccator for further characterization. In addition, cast films are prepared with optimized drug-polymer concentrations, following a similar preparation process. These films are dried in a vacuum chamber for 72 hours under controlled environmental conditions (25 ± 2°C and 40 ± 5% relative humidity).
The molecular formula of domperidone is C22H24ClN5O2.
The molecular weight of domperidone is 425.9 g/mol.
The IUPAC name of domperidone is 6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one.
The InChIKey of domperidone is FGXWKSZFVQUSTL-UHFFFAOYSA-N.
The synonyms of domperidone are Motilium, Domperidona, and Domperidonum.
Domperidone has the role of being an antiemetic and a dopaminergic antagonist.
Domperidone is a specific blocker of dopamine receptors.
Domperidone is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism.
Domperidone binds to dopamine receptor D2 (D2R) expressed by peripheral neurons, inhibiting dopamine binding and D2R-mediated signaling. This helps relieve various gastrointestinal symptoms such as nausea and vomiting.
The CAS number for domperidone is 57808-66-9. Other identifiers include CAS Common Chemistry, ChemIDplus, DrugBank, DTP/NCI, EPA DSSTox, European Chemicals Agency (ECHA), FDA Global Substance Registration System (GSRS), and Human Metabolome Database (HMDB).